首页 | 本学科首页   官方微博 | 高级检索  
检索        

基质金属蛋白酶及微血管密度和子宫内膜癌的关系
引用本文:张宇靖,张首杰.基质金属蛋白酶及微血管密度和子宫内膜癌的关系[J].中国妇幼健康研究,2003,14(6):425-427.
作者姓名:张宇靖  张首杰
作者单位:吉林大学第二临床医学院妇产科,吉林,长春,130041
摘    要:基质金属蛋白酶及其抑制剂在子宫内膜癌的侵袭和转移中发挥着重要的作用。肿瘤的新生血管对肿瘤的发生、发展、转移及预后有着重要作用。微血管密度是衡量血管生成的定量指标。基质金属蛋白酶抑制剂可抑制血管的生成和MMPs对细胞外基质的降解。现将他们与子宫内膜癌的关系综述如下。

关 键 词:基质金属蛋白酶  金属蛋白酶抑制剂  血管生成  子宫内膜癌
文章编号:1008-2514(2003)06-425-3
修稿时间:2003年5月8日

The relations of matrix metalloproteinases and the density of microvessel in tumours with endometrial carcinoma
ZHANG Yu jing,ZHANG Shou jie.The relations of matrix metalloproteinases and the density of microvessel in tumours with endometrial carcinoma[J].Chinese Journal of Maternal and Child Health Research,2003,14(6):425-427.
Authors:ZHANG Yu jing  ZHANG Shou jie
Abstract:Matrix metalloproteinases(MMPs)and tissue inhibitor of metalloproteinases(TIMPs) play important roles in the invasion and metastasis of endometrial carcinoma.The neogenetic blood vessels of tumor is of crucial role in occurrence, development, matastasis and prognosis of the tumor. The microvessel density(MVD)is a quantitative index of angiogenesis. TIMPs can inhibit not only angiogenesis but also degradation of extracellular matrix (ECM)by MMPs. We summarized the relations of the two substances with carcinoma of endometrium as follows.
Keywords:matrix metalloproteinases(MMPs)  tissue inhibitor of metalloproteinases(TIMPs)  angiogenesis  endometrial carcinoma
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号